EUVIMEDEUVIMED entdecken
Open Access

Common Cancer Types and Risk of Stroke and Bleeding in Patients With Nonvalvular Atrial Fibrillation: A Population‐Based Study in England

Alyaa M Ajabnoor iD, Rosa Parisi iD, Salwa S Zghebi iD, Darren M Ashcroft iD, Corinne Faivre-Finn iD, Charlotte Morris, Mamas A Mamas iD, Evangelos Kontopantelis iD

Journal of the American Heart Association · 03.10.2023 · 12 (19)

DOI: 10.1161/jaha.123.029423 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, erschienen am 03.10.2023. Verfasst von Alyaa M Ajabnoor und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Practice, Faculty of Pharmacy King Abdulaziz University Jeddah Saudi Arabia. Hauptthemen laut MEDLINE: Atrial Fibrillation, Stroke, Prostatic Neoplasms, Breast Neoplasms. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The association between cancer and stroke or bleeding outcomes in atrial fibrillation is unclear. We sought to examine how certain types of cancer influence the balance between stroke and bleeding risk in patients with nonvalvular atrial fibrillation (NVAF). Methods and Results We estimated stroke and bleeding risk among adult patients with NVAF and certain types of cancer (breast, prostate, colorectal, lung, and hematological cancer) from 2009 to 2019 based on data from the UK Clinical Practice Research Datalink GOLD and Aurum databases. The control group included patients with NVAF only. Of 177 065 patients with NVAF, 11379 (6.4%) had cancer (1691 breast, 3955 prostate, 1666 colorectal, 2491 hematological, and 1576 lung). Compared with patients without cancer, stroke risk was higher in patients with breast cancer (adjusted hazard ratio [aHR], 1.20 [95% CI, 1.07–1.35) and with prostate cancer (aHR, 1.11 [95% CI, 1.01–1.12) if diagnosed within 6 months before NVAF. The risk of bleeding was increased in subjects with hematological cancer (aHR, 1.55 [95% CI, 1.40–1.71]), lung cancer (aHR, 1.49 [95% CI, 1.25, 1.77]), prostate cancer (aHR, 1.38 [95% CI, 1.28–1.49]), and colorectal cancer (aHR, 1.36 [95% CI, 1.21–1.53]), but not for subjects with breast cancer. The more recent the cancer diagnosis before NVAF diagnosis (within 6 months), the higher the risk of bleeding.

Conclusions

Breast and prostate cancer are associated with increased stroke risk, whereas in some cancer types, the risk of bleeding seemed to exceed stroke risk. In these patients, prescribing of oral anticoagulant should be carefully evaluated to balance bleeding and stroke risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationStrokeProstatic NeoplasmsBreast NeoplasmsHematologic NeoplasmsColorectal NeoplasmsMaleAdultHumansHemorrhageAnticoagulantsRetrospective Studies

Stichwörter der Autor:innen

atrial fibrillationbleedingcanceroral anticoagulantstroke

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Department of Pharmacy Practice, Faculty of Pharmacy King Abdulaziz University Jeddah Saudi Arabia.
  • Division of Informatics, Imaging and Data Sciences, School of Health Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre (MAHSC) University of Manchester Manchester United Kingdo…
  • Division of Population Health, Health Services Research and Primary Care, School of Health Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre (MAHSC) University of Manchester Ma…
  • Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health University of Manchester Manchester United Kingdom.
  • National Institute for Health and Care Research (NIHR) Greater Manchester Patient Safety Research Collaboration (PSRC) University of Manchester Manchester United Kingdom.
  • The Christie NHS Foundation Trust and The University of Manchester Manchester United Kingdom.

ORCID-Profile: Alyaa M Ajabnoor, Rosa Parisi, Salwa S Zghebi, Darren M Ashcroft, Corinne Faivre-Finn, Mamas A Mamas, Evangelos Kontopantelis

Zitieren

APA

Ajabnoor, A. M., Parisi, R., Zghebi, S. S., Ashcroft, D. M., Faivre-Finn, C., Morris, C., Mamas, M. A., & Kontopantelis, E. (2023). Common Cancer Types and Risk of Stroke and Bleeding in Patients With Nonvalvular Atrial Fibrillation: A Population‐Based Study in England. Journal of the American Heart Association, 12(19). https://doi.org/10.1161/jaha.123.029423

Vancouver

Ajabnoor AM, Parisi R, Zghebi SS, Ashcroft DM, Faivre-Finn C, Morris C, et al. Common Cancer Types and Risk of Stroke and Bleeding in Patients With Nonvalvular Atrial Fibrillation: A Population‐Based Study in England. Journal of the American Heart Association. 2023;12(19). doi:10.1161/jaha.123.029423

BibTeX
@article{Ajabnoor2023,
  author = {Ajabnoor, Alyaa M and Parisi, Rosa and Zghebi, Salwa S and Ashcroft, Darren M and Faivre-Finn, Corinne and Morris, Charlotte and Mamas, Mamas A and Kontopantelis, Evangelos},
  title = {Common Cancer Types and Risk of Stroke and Bleeding in Patients With Nonvalvular Atrial Fibrillation: A Population‐Based Study in England},
  journal = {Journal of the American Heart Association},
  year = {2023},
  volume = {12},
  number = {19},
  doi = {10.1161/jaha.123.029423}
}
Kostenlos starten →